Health technology company Koite Health and technology company Reaktor have together developed a new mobile application supporting oral health, the Lumoral app. The application assists users in maintaining sustainable oral care practices, aiming to seamlessly integrate modern technology into the daily oral hygiene routines of Lumoral users.

Lumoral is a Finnish dental innovation that effectively and comprehensively removes harmful mouth bacteria through a light-activated mouth rinse. With the new application, users of the Lumoral method can establish new and enduring dental care routines, which help to motivate regular Lumoral usage for the benefit of oral health.

"The effectiveness of Lumoral treatment is parallel to the user's treatment frequency. For this reason, we want to facilitate our users in building their own Lumoral routine. The Lumoral app enables easy and automated ordering of Lumorinse tablets and the creation of a personalized Lumoral usage routine with reminders. The application also enables tracking of one's own oral health development and Lumoral device usage history," says Sakari Nikinmaa, CEO of Koite Health Oy.

The free Lumoral app includes, among other features, a customized Lumoral coaching program, an intelligent calendar, reminders, and a statistics page for monitoring oral health progress. Through the app, users can also collect usage data, which can help track the improvement of their oral health.

"Understanding the Lumoral device and users' needs was essential when we embarked on developing the Lumoral app together. Extensive testing and research phases provided valuable insights, guiding the creation of an intuitive user experience," says Marko Sibakov, Business Director of Reaktor Health.

"We paid special attention to simplifying the ordering of Lumorinse tablets. Now you can easily purchase them from the app's own store."

Collaboration with Reaktor ensured that the vision of the Lumoral app was seamlessly aligned with user needs.

"This is Koite Health's first digital product, and we wanted to choose the best partner to realize it. Reaktor's international expert team and customer-centric approach helped create a first-class solution. We are excited and listening closely to how the Lumoral family receives the new app," comments Pekka Ruuska, Marketing Director of Koite Health Oy.

For more information for the media:

Sakari Nikinmaa

CEO, Koite Health

+358 40 8222 034, sakari@koitehealth.com

Koite Health

Koite Health is a Finnish health technology company whose double-light-based innovation has revolutionized Finnish oral health care. The company's expert team consists of experienced doctors and technology professionals. The company's founders Sakari Nikinmaa, Tommi Pätilä, and Juha Rantala established Koite Health in September 2018 as part of significant medical innovation commercialization projects funded by Business Finland and Aalto University. Koite Health was named one of Europe's top health technology companies in the Tech Tour 22 competition.

The Lumoral developed by the company is a dental cleaning device used in addition to regular tooth brushing. The device is suitable for everyone but is particularly important for those with cavities or gum inflammation. Lumoral has been scientifically developed, and its antibacterial efficacy has been well established. Lumoral is a Class II medical device and CE certified.

Reaktor

Reaktor is a technology company that designs and builds leading digital products and services in collaboration with its clients. Founded in 2000, the company has 700 employees and offices in Helsinki, Turku, Tampere, New York, Amsterdam, Lisbon, Stockholm, and Tokyo. Its clients include brands such as Adidas, HBO, Supercell, Cathay Pacific, and KONE.

Reaktor Health specializes in building digital solutions with healthcare service providers in Europe. Reaktor Health helps healthcare operators improve their services and interaction with patients, delivers high-quality software solutions quickly, supports product launches, and strengthens its clients' competitiveness.

The Nokia Rubber Workers' Sickness Fund (Nokian Kumiväen Sairauskassa) has entered into a partnership agreement with Finnish health technology company Koite Health Oy, deciding to increasingly focus on the oral health of its insured members. The fund will now reimburse the costs of Lumoral treatment for its insured members, providing a valuable additional benefit for maintaining oral health.

Lumoral is an innovative Finnish health technology solution that supports users' oral health by treating and preventing infections of the teeth and gums. The fund sees its solution as an important step towards preventive healthcare.

– The decision is based on thorough consideration and discussions with the fund's board. The board recognized the opportunities offered by the Lumoral device and unanimously decided to approve it as part of the benefits offered by the sickness fund, says Piia Virolainen, CEO of the Nokia Rubber Workers' Sickness Fund.

Piia Virolainen, CEO of the Nokia Rubber Workers' Sickness Fund.

Studies show that poor oral health is one of the major risk factors behind many common diseases, as inflamed gums and damaged tooth surfaces provide a direct route for bacteria.

– Oral infections are remarkably common globally, and they contribute to the onset of serious conditions such as cancer, diabetes, heart, lung, and kidney diseases, says Tommi Pätilä, a heart and organ transplant surgeon at HUS Children's Hospital, in Helsinki. Pätilä is also one of the developers of the Lumoral method.

– As the population ages, we are inevitably heading towards difficult times in healthcare and its financial management. Oral infections significantly increase the need for hospitalization and its complications. Therefore, investing in oral care and its comprehensive understanding – especially in the prevention of dental diseases – pays off multiple times in the future, Pätilä continues.

Oral diseases are a significant expense

According to Virolainen, the decision will practically mean that regular Lumoral treatment, including Lumorinse tablets, will be covered for the health fund's insured members as part of the fund's dental benefit.

– Regular Lumoral treatment has an impact on oral health, but it also affects the overall well-being of its users. The Nokia Rubber Workers' Sickness Fund is constantly striving to improve the well-being and health of its insured members. The reimbursement of Lumoral device and Lumorinse tablets is one step towards this goal, emphasizes Virolainen.

Virolainen states that the Nokia Rubber Workers' Sickness Fund reimburses the most research and treatment costs. The next highest reimbursement is for insured members' dental treatment costs.

– Dental diseases can lead to significant costs, making our fund's dental benefit a highly valued and frequently utilized resource among our insured members. Quick access to dental care, without the inconvenience of waiting, is considered essential by our insured members, Virolainen adds.

According to Lumoral Area Manager Riikka Nisula, local dental clinics have eagerly welcomed the decision of the Nokia Rubber Workers' Sickness Fund to reimburse Lumoral and Lumorinse tablets because prevention and enhancing self-care support professional treatment.

The antibacterial Lumoral treatment effectively removes harmful bacteria from the surfaces of the teeth and gum lines. Home-administered Lumoral treatment has been found to be significantly more effective and better tolerated than chlorhexidine-based mouthwashes, which are commonly used today.

Nisula emphasizes that the antibacterial treatment is carried out as an additional treatment to mechanical teeth cleaning and does not replace the need to brush teeth and clean between teeth. So why is additional treatment to enhance mechanical oral hygiene needed?

According to studies, brushing teeth removes only 65% of plaque. Residual plaque remains in the mouth after even the most effective teeth brushing. Lumoral helps to remove this residual plaque. With regular Lumoral treatment, the tooth surfaces are properly cleaned.

Antibacterial treatment has also been shown to prevent and treat infections of the tissues surrounding implants. The treatment is suitable for everyone, but light-activated antibacterial treatment is seen as most effective for patients who need enhanced oral hygiene.

The Nokia Rubber Workers' Sickness Fund is a so-called supplementary fund that reimburses insured members for additional benefits according to its rules. The fund has about 1,200 insured members. Altogether, there are about 110 health funds operating in Finland, whose insured members consist of employees and/or office personnel. In many funds, retirees can continue to be insured by the fund, and in some funds, family members are also entitled to reimbursements.

For more information:  

Sakari Nikinmaa
CEO, Koite Health
+358 40 8222 034, sakari@koitehealth.com

Piia Virolainen
CEO, Nokian Kumiväen Sairauskassa
+358 50577015,5 toimisto@nokiankumivaensairauskassa.fi

Finnish health technology company Koite Health Oy has signed a distribution agreement with a Danish distributor of specialized dentistry products in the tissue regenerative and surgical fields, such as dental implantology. Following the accord, Puredent ApS will also offer Lumoral® – the latest technology for improved oral health self-care – to consumers and oral health professionals in the Danish and Icelandic markets.

– Common to the solutions that we offer is that they can differentiate clinics from other clinics and help their patients reach better oral health, says Thomas Boas, Founder and CEO of Puremedical Group ApS.

Puredent is part of the Danish Puremedical Group – a company that operates in the dentistry, medical and veterinary fields. Thus far, the company's dentistry business has offered solutions mainly for the dental repair and restoration segments. Following the Lumoral agreement, Puredent will focus more marketing efforts on the continuously growing preventative oral care market in Denmark and Iceland. 

According to Boas, Lumoral is a unique product that helps prevent and treat common oral diseases such as gingivitis, periodontitis, and dental caries. 

Dental caries is the most common infectious disease in the world. According to the World Health Organisation (WHO), severe periodontal diseases are estimated to affect around 19% of the global adult population, representing over 1 billion cases worldwide. The main risk factors for periodontal disease are poor oral hygiene and tobacco use.

Boas notes that Lumoral fits well in the company's product line as more and more dentists and medical physicians are beginning to understand the close link between oral and general health. This also means that a growing number of dentists are starting to put increased emphasis on oral disease prevention.

Boas stresses that the current dental market situation differs from the pre-Covid-19 era five years ago. This is when Puredent first sought to enter the preventive oral health market with an innovative diagnostics test that reveals whether a person has periodontal disease or not in their mouth. The so-called Matrix metalloproteinase-8 immunological test (aMMP-8) developed by Dr. Timo Sorsa – Professor of Periodontology at Helsinki University and Karolinska University – helps detect whether there is a periodontal degradation process taking place in a person's gum pocket before it is even possible to see visually.

Professor Sorsa is one of the most respected periodontal researchers in the world. He has been developing and patenting many solutions for treating periodontitis, including the most validated clinical test for active periodontitis identification. 

– The market in Denmark was not ready then, but it is ready now. Increased knowledge of the link between oral diseases and general health encourages oral health professionals to provide early diagnosis and preventive care. This is where both the antibacterial Lumoral method and the aMMP-8 diagnostics test come in handy,  Boas notes.

According to Boas, even the Danish Association of Dentists is pushing the "Healthy Mouth, Healthy Body" theme today.

– Lumoral is a novel product category in preventative oral care. Minimal effort can have a significant effect. If you look at this from the dentists' point of view, Lumoral is a way to improve their patient's overall health as home care between the dental appointments.

According to Boas, the signed distribution deal helps to bridge Puremedical Group's dentistry and medical businesses closer together and create synergy benefits. 

Thomas Boas, Founder and CEO of Puremedical Group ApS.

Lumoral – a novel, cutting-edge technology 

The agreement between Koite Health and Puredent includes all activities necessary to launch a novel medical device and a new technology in the Danish and Icelandic markets. According to Boas, the agreement will initially mean focusing on B2C operations, making the Lumoral method available to the Danish consumer and Icelandic users through a local partner of Puredent.

Through extensive communication, the company seeks to ensure that dental professionals in the Danish B2B market are also introduced early to the benefits of Lumoral treatment so that they can start recommending the treatment to their patients.

Boas points out that good oral hygiene requires adequate motor and mental skills. For example, flossing or brushing can be difficult because of age or physical disability, leaving bacteria-filled dental plaque between teeth. On the other hand, even when brushing teeth perfectly, studies show that an effective electric toothbrush only removes about 65% of harmful oral bacteria.

– With Lumoral you can't go wrong. This is why the Lumoral method is so unique. With brushing and flossing, you must follow strict procedures (twice a day, 7 days a week, 2 minutes tooth brushing) to remove plaque efficiently from your mouth and reach optimal oral health. Still, the efforts might not be enough. With Lumoral you just swish the mouthwash in your mouth and then let the antibacterial effect of the mouthpiece do its work.

Boas says that it is crucial that scientific evidence of Lumoral's efficacy is communicated directly to dental professionals to help spread the message of Lumoral's scientifically proven effect on oral health. Several scientific studies that clearly show the clinical impact of Lumoral's antibacterial dual light therapy have already been released.

Lumoral is changing the future of dental care at home

Research shows that Lumoral's antibacterial aPDT phototherapy effectively eliminates harmful bacteria in the mouth while treating advanced gum disease. Similar light-activated antibacterial treatments have been used in dental clinics, for example. However, the problem has been the cost and frequency of these treatments to provide sufficient efficacy. 

Preventive health care, which includes the use of the antibacterial Lumoral method to improve oral hygiene, will quickly pay for itself. Preventive oral health care also brings significant savings to society. This applies not only to dental care but to the entire healthcare system. Lumoral supports regular mechanical dental hygiene, helps achieve gum health, and prevents inflammation when regular dental hygiene is insufficient.

Puredent aims at providing its customers with the best possible modern treatment for oral diseases.  

Boas sees multiple groups of people who can benefit most from using Lumoral. These include patients undergoing orthodontic treatment, patients into fitness sports and promoting healthy living habits, elderly patients with limited motor abilities, and competitive athletes as well as patient groups in cancer, diabetes and rheumatoid arthritis.

– The timing of this cooperation is likely to be very good. This cooperation is an exciting tool for expanding into the prevention business.

Sakari Nikinmaa, Koite Health's CEO, the partnership agreement's benefits are mutual. Partnership with Thomas Boas and his Puredent team are an important step for Lumoral to strengthen its reach in the Scandinavian market.

– Our strategy is to partner with industry leaders to raise awareness among professionals about the Lumoral product and its benefits and to build a global sales structure to secure product availability globally.

– By working together, we can take oral health to a new level and provide patients with the best possible treatment experience and outcomes. Koite Health's clinical results and Puredent's expertise and organization are perfectly combined with Lumoral's unique features and efficiency, says Nikinmaa.

Sakari Nikinmaa, Co-founder and CEO of Koite Health Oy.